Your browser doesn't support javascript.
loading
The anti-breast cancer potential of indole/isatin hybrids.
Wang, Ruo; Huang, Renhong; Yuan, Yaofeng; Wang, Zheng; Shen, Kunwei.
Affiliation
  • Wang R; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Huang R; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yuan Y; Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), Department of Chemistry, Fuzhou University, Fuzhou, China.
  • Wang Z; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shen K; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Arch Pharm (Weinheim) ; 356(11): e2300402, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37650315

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Isatin / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Arch Pharm (Weinheim) Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Isatin / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Arch Pharm (Weinheim) Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany